Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.

The company recently completed a massive expansion in Durham and is acquiring a Raleigh company for billions. Join us as we honor outstanding C-Level Executives for their invaluable contributions to ...

Merck, a major New Jersey-based pharma company currently developing a vaccine against HPV, has decided to expand its facilities here in the region, investing around $650 million and creating more ...

A former FDA safety officer inspected Merck’s Durham, North Carolina, plant and said hygiene concerns were downgraded. Merck is going to help make Johnson & Johnson COVID vaccine.

Merck recently disclosed plans to expand its hiring in Durham by 100 more employees in the next few years to hike output of a bladder cancer drug.

DURHAM The federal government will spend $105.4 million outfitting Merck’s Durham plant for the production of Johnson & Johnson’s COVID-19 vaccine, Merck confirmed Wednesday.

Verona Pharma's flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease in more than a decade.

A former FDA safety officer inspected Merck’s Durham, North Carolina, plant and said hygiene concerns were downgraded. Merck is going to help make Johnson & Johnson COVID vaccine.

Merck’s 262-acre facility in north Durham will be one of two in the country to help ramp up manufacturing of Johnson & Johnson’s one-shot vaccine — part of a massive effort to help stop the ...

A former FDA safety officer inspected Merck’s Durham, North Carolina, plant and said hygiene concerns were downgraded. Merck is going to help make Johnson & Johnson COVID vaccine.

According to a federal database, Merck’s Durham facility has not been inspected since 2018. Before that it was inspected in 2016 and 2014. Its 2020 on-site inspection was put off due to the ...